Back to search
FDAFDA · Food and drugs·Recall number D-0001-2026

Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Published October 8, 2025 · Recall initiated: September 24, 2025

Summary

FDA records drug Class II recall D-0001-2026, published October 8, 2025 and initiated September 24, 2025. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Reported quantity: 912 30-count bottles; Lot: Lot#: E409308, Exp 12/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

What to do

Voluntary: Firm initiated · Letter

Get an email if ENTECAVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ENTECAVIR
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Distributed Nationwide in the USA
Lot
Lot#: E409308, Exp 12/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06. recalled?

Yes. FDA published recall D-0001-2026 on October 8, 2025. Reported hazard: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ENTECAVIR.